ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis
Authors
Keywords
-
Journal
CELL DEATH AND DIFFERENTIATION
Volume 21, Issue 4, Pages 612-623
Publisher
Springer Nature America, Inc
Online
2014-01-10
DOI
10.1038/cdd.2013.186
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer
- (2012) James G. Jackson et al. CANCER CELL
- Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis
- (2012) F Nikulenkov et al. CELL DEATH AND DIFFERENTIATION
- p53-dependent inhibition of TrxR1 contributes to the tumor-specific induction of apoptosis by RITA
- (2011) Elisabeth Hedström et al. CELL CYCLE
- Abrogation of Wip1 expression by RITA-activated p53 potentiates apoptosis induction via activation of ATM and inhibition of HdmX
- (2011) C Spinnler et al. CELL DEATH AND DIFFERENTIATION
- Recent Advances in the Therapeutic Perspectives of Nutlin-3
- (2011) Paola Secchiero et al. CURRENT PHARMACEUTICAL DESIGN
- Inhibition of Glycolytic Enzymes Mediated by Pharmacologically Activated p53
- (2011) Joanna Zawacka-Pankau et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chromosomal breaks during mitotic catastrophe trigger γH2AX–ATM–p53-mediated apoptosis
- (2011) Gabriela Imreh et al. JOURNAL OF CELL SCIENCE
- New insights into oncogenic stress
- (2011) Kevin M Haigis et al. NATURE GENETICS
- The stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression
- (2011) Daniel Schramek et al. NATURE GENETICS
- The biological and therapeutic relevance of mRNA translation in cancer
- (2011) Sarah P. Blagden et al. Nature Reviews Clinical Oncology
- Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1
- (2011) A Ahmed et al. Cell Death & Disease
- Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS production
- (2010) Xu He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Noble metal targeting of thioredoxin reductase — covalent complexes with thioredoxin and thioredoxin-related protein of 14kDa triggered by cisplatin
- (2010) Stefanie Prast-Nielsen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Wild-type p53-induced Phosphatase 1 Dephosphorylates Histone Variant γ-H2AX and Suppresses DNA Double Strand Break Repair
- (2010) Sung-Hwan Moon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of oxidatively induced DNA lesions in human pathogenesis
- (2010) Olga A. Sedelnikova et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Selective activation of p53-mediated tumour suppression in high-grade tumours
- (2010) Melissa R. Junttila et al. NATURE
- Stage-specific sensitivity to p53 restoration during lung cancer progression
- (2010) David M. Feldser et al. NATURE
- Wip1 phosphatase is associated with chromatin and dephosphorylates γH2AX to promote checkpoint inhibition
- (2010) L Macůrek et al. ONCOGENE
- A minority of foci or pan-nuclear apoptotic staining of H2AX in the S phase after UV damage contain DNA double-strand breaks
- (2010) S. de Feraudy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic targeting of p53 by small molecules
- (2010) Galina Selivanova SEMINARS IN CANCER BIOLOGY
- Selenoproteins that function in cancer prevention and promotion
- (2009) Dolph L. Hatfield et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Ablation of Key Oncogenic Pathways by RITA-Reactivated p53 Is Required for Efficient Apoptosis
- (2009) Vera V. Grinkevich et al. CANCER CELL
- MDM2-Dependent Downregulation of p21 and hnRNP K Provides a Switch between Apoptosis and Growth Arrest Induced by Pharmacologically Activated p53
- (2009) Martin Enge et al. CANCER CELL
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- WIP1 phosphatase at the crossroads of cancer and aging
- (2009) Xavier Le Guezennec et al. TRENDS IN BIOCHEMICAL SCIENCES
- The Novel Polyamine Analogue CGC-11093 Enhances the Antimyeloma Activity of Bortezomib
- (2008) J. S. Carew et al. CANCER RESEARCH
- Mcl-1 is a potential therapeutic target in multiple types of cancer
- (2008) C. Akgul CELLULAR AND MOLECULAR LIFE SCIENCES
- The PIK3CA Gene as a Mutated Target for Cancer Therapy
- (2008) John Gustin et al. CURRENT CANCER DRUG TARGETS
- Transcriptional control of human p53-regulated genes
- (2008) Todd Riley et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cell Death by SecTRAPs: Thioredoxin Reductase as a Prooxidant Killer of Cells
- (2008) Karin Anestål et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started